Your browser doesn't support javascript.
loading
Bevacizumab plus erlotinib in Chinese patients with untreated, EGFR-mutated, advanced NSCLC (ARTEMIS-CTONG1509): A multicenter phase 3 study.
Zhou, Qing; Xu, Chong-Rui; Cheng, Ying; Liu, Yun-Peng; Chen, Gong-Yan; Cui, Jiu-Wei; Yang, Nong; Song, Yong; Li, Xiao-Ling; Lu, Shun; Zhou, Jian-Ying; Ma, Zhi-Yong; Yu, Shi-Ying; Huang, Cheng; Shu, Yong-Qian; Wang, Zhen; Yang, Jin-Ji; Tu, Hai-Yan; Zhong, Wen-Zhao; Wu, Yi-Long.
Afiliação
  • Zhou Q; Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China.
  • Xu CR; Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China.
  • Cheng Y; Department of Thoracic Oncology, Jilin Provincial Tumor Hospital, Changchun, China.
  • Liu YP; Department of Medical Oncology, First Hospital of China Medical University, Shenyang, China.
  • Chen GY; Medical Oncology, Cancer Hospital of Harbin Medical University, Harbin, China.
  • Cui JW; Cancer Center, First Hospital of Jilin University, Changchun, China.
  • Yang N; Department of Medical Oncology, Hunan Cancer Hospital, Changsha, China.
  • Song Y; Department of Respiratory Medicine, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China.
  • Li XL; Medical Oncology, Liaoning Cancer Hospital, Shenyang, China.
  • Lu S; Medical Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
  • Zhou JY; Respiratory Medicine, First Affiliated Hospital of College of Medicine, Zhejiang University, Hangzhou, China.
  • Ma ZY; Department of Respiratory Medicine, Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital, Zhengzhou, China.
  • Yu SY; Medical Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Huang C; Medical Oncology, Fujian Cancer Hospital, Fuzhou, China.
  • Shu YQ; Medical Oncology, First Affiliated Hospital, Nanjing Medical University, Nanjing, China.
  • Wang Z; Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China.
  • Yang JJ; Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China.
  • Tu HY; Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China.
  • Zhong WZ; Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China.
  • Wu YL; Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China. Electronic address: syylwu@live.cn.
Cancer Cell ; 39(9): 1279-1291.e3, 2021 09 13.
Article em En | MEDLINE | ID: mdl-34388377
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Carcinoma Pulmonar de Células não Pequenas / Cloridrato de Erlotinib / Bevacizumab / Neoplasias Pulmonares Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Cell Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Carcinoma Pulmonar de Células não Pequenas / Cloridrato de Erlotinib / Bevacizumab / Neoplasias Pulmonares Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Cell Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China